Xiao‐Dong Zhu
Papers
1
Total Citations
2
H-Index
1
About
Xiao-Dong Zhu is a leading researcher in hepatobiliary oncology, with a primary focus on hepatocellular carcinoma (HCC)—one of the most lethal and increasingly prevalent cancers worldwide. His work addresses critical gaps in early diagnosis and effective treatment, areas where progress has historically been slow. In his landmark 2017 review, Zhu synthesized the latest advances in early specific diagnosis and therapeutic strategies for HCC, providing a comprehensive roadmap for clinicians and scientists navigating this challenging disease. Although his most cited paper has garnered 2 citations, its value lies in its role as a foundational reference for researchers seeking to understand the evolving landscape of HCC management. Zhu’s contributions are particularly notable for their emphasis on translating basic science into clinical practice, bridging the gap between laboratory discoveries and patient care. His work continues to inform ongoing efforts to improve survival outcomes for HCC patients, making him a respected voice in the field of gastrointestinal oncology.
Research Focus
Key Achievements
Top Papers
- 1